Several FSHD mouse models exist, some of them engineered for inducible and tissue-specific DUX4 overexpression, and will be instrumental to assess to what extent and through which mechanism loss of Fat1 function could synergize with enhanced DUX4 levels [123–126]. This evidence concerns the gene DUX4 and Facioscapulohumeral dystrophy.